Hartmut Retzlaff
Directeur/Membre du Conseil chez Eurogenerics NV
Profil
Hartmut Retzlaff is currently a Director at Clonmel Healthcare Ltd., STADA Financial Investments Ltd., STADA Pharmaceuticals (Asia) Ltd., and a Member-Supervisory Board at Eurogenerics NV, STADApharm AB, and Stada Vietnam J.V.
Co. Ltd.
He was formerly the Chairman-Management Board at STADA Arzneimittel AG from 1992 to 2016.
He also held positions as Chairman at Hemofarm AD, Director at OY Stada Pharma AB and SFS International Ltd., and Member-Supervisory Board at NeoCare NV.
Postes actifs de Hartmut Retzlaff
| Sociétés | Poste | Début |
|---|---|---|
| Eurogenerics NV | Directeur/Membre du Conseil | - |
Clonmel Healthcare Ltd.
 Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | - |
| STADA Financial Investments Ltd. | Directeur/Membre du Conseil | - |
| STADApharm AB | Directeur/Membre du Conseil | - |
| STADA Pharmaceuticals (Asia) Ltd. | Directeur/Membre du Conseil | - |
| Stada Vietnam J.V. Co. Ltd. | Directeur/Membre du Conseil | 01/09/2013 |
Anciens postes connus de Hartmut Retzlaff
| Sociétés | Poste | Fin |
|---|---|---|
| STADA ARZNEIMITTEL | Directeur Général | 05/06/2016 |
| SFS International Ltd. | Directeur/Membre du Conseil | - |
| OY Stada Pharma AB | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Hemofarm AD
 Hemofarm AD Pharmaceuticals: MajorHealth Technology Hemofarm AD engages in the manufacture, sale, and distribution of pharmaceutical products. The company was founded on June 1, 1960 and is headquartered in Vrsac, Serbia. | Health Technology |
Clonmel Healthcare Ltd.
Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Health Technology |
| Eurogenerics NV | |
NeoCare NV
 NeoCare NV Pharmaceuticals: MajorHealth Technology Part of STADA Arzneimittel AG, NeoCare NV is a Belgian company that manufactures and supplies pharmaceuticals. The company is based in Brussels, Belgium. | Health Technology |
| OY Stada Pharma AB | |
| SFS International Ltd. | |
| STADA Financial Investments Ltd. | |
| STADApharm AB | |
| STADA Pharmaceuticals (Asia) Ltd. | |
| Stada Vietnam J.V. Co. Ltd. |